Home > Contact Us
Contact Us
For more information call: (844) 782–4278
Corporate Headquarters
305 Madison Avenue
Morristown, NJ 07960
T: (646) 747–1000
Inquiries
Partnering inquiries
Investigator-initiated research inquiries
Medical educational grant requests
Medical Expanded Access Program Requests
All other inquiries
YOU ARE NOW leaving interceptpharma.com
You are now leaving Intercept Pharmaceuticals’ corporate website and entering a site intended for U.S. audiences only.
YOU ARE NOW leaving interceptpharma.com
You are now leaving Intercept Pharmaceuticals’ corporate website. Intercept does not control or endorse the content of this external site.
YOU ARE NOW leaving interceptpharma.com
The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website.
The site you will be entering is intended for U.S. audiences only.
If you are a healthcare provider looking for product information, visit ocalivahcp.com.
YOU ARE NOW leaving interceptpharma.com
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.
Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed.
United States (US)
European Union (EU)
Canada
Israel
Switzerland
Australia
Liechtenstein
United Arab Emirates (UAE)
Exploring Racial Differences and Disparities in PBC Care
Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., announced its decision to voluntarily withdraw OCALIVA® (obeticholic acid) from the US market for the treatment of primary biliary cholangitis (PBC), a rare, progressive liver disease.
Healthcare professionals can contact Medical Information at medinfo@interceptpharma.com or call 1-844-782-4278. Patients should talk to their healthcare professionals and may also contact Intercept's Patient Support Services (Interconnect) at 1-844-622-4278.
For all other inquiries please visit: https://www.interceptpharma.com/
Please click here for Full Prescribing Information and Medication Guide for OCALIVA.